Table 7.
Monitoring of side effects.
| Type of monitoring | Frequency | Percentage |
|---|---|---|
| At initiation of psychotropic medication | ||
| Blood pressure & heart rate | 226 | 33.6 |
| Weight | 157 | 23.3 |
| Temperature | 207 | 30.6 |
| Fasting blood glucose | 83 | 12.3 |
| Lipids | 1 | 0.1 |
| At least 6 months after drug initiation | ||
| Blood pressure & heart rate | 159 | 32.8 |
| Weight | 135 | 27.8 |
| Temperature | 152 | 31.3 |
| Fasting blood glucose | 39 | 8.1 |
| As indicated in patient records | ||
| Blood pressure & heart rate | 178 | 33.7 |
| Weight | 141 | 26.8 |
| Temperature | 170 | 32.2 |
| Fasting blood glucose | 37 | 6.9 |
| Lipids | 1 | 0.2 |
| Complete blood count | 1 | 0.2 |
| Liver function | 1 | 0.2 |
There are multiple responses to the type of therapeutic monitoring conducted. No measurements for drug levels in blood were conducted.